Showing results (221-230 of 4,510) with videos related to
Sort By:
Pageof 451
Future Oncology (London, England)|March 24, 2025
Molecular shifts in breast cancer following neoadjuvant chemotherapy: a prospective study and review of literatureAvinash Chandra Singh, Kalyan Pandey, Sumit Agarwal, et al.Future Oncology (London, England)|March 24, 2025
Treatment intensification in metastatic castration-sensitive prostate cancer: a real-world study in Alberta, CanadaSteven M Yip, Winson Y Cheung, Armen Aprikian, et al.Future Oncology (London, England)|March 26, 2025
Contemporary real-world treatment in metastatic hormone-sensitive prostate cancer: US, four European countries, and UKPeter J Goebell, Stephanie Chen, Jay JhaveriFuture Oncology (London, England)|March 24, 2025
Clinical characterization and therapeutic targeting of fusion genes in oncologySusan Morand, Lauren Rager, Daniel Craig, et al.Future Oncology (London, England)|March 19, 2025
Nausea and vomiting in an evolving anticancer treatment landscape: long-delayed and emetogenic antibody-drug conjugatesYeon Hee Park, Giampaolo Bianchini, Javier Cortés, et al.Future Oncology (London, England)|May 8, 2013
New prospects for drug development: the hedgehog pathway revealed. Focus on hematologic malignanciesAgustin Pimentel, Michel Velez, Luz J Barahona, et al.Future Oncology (London, England)|May 8, 2013
Hairy cell leukemia in a patient with situs inversus totalis: an extremely rare combinationPrajwol Pathak, Valeria Zilberman, Boris Avezbakiyev, et al.Future Oncology (London, England)|February 19, 2013
Urological medical oncology: land of opportunityRobert JonesFuture Oncology (London, England)|February 19, 2013
Tivantinib: a new promising mesenchymal-epithelial transition factor inhibitor in the treatment of hepatocellular carcinomaLorenza Rimassa, Nicola Personeni, Matteo Simonelli, et al.Future Oncology (London, England)|February 19, 2013
MITF, the Janus transcription factor of melanomaDana Koludrovic, Irwin DavidsonPageof 451